prazosin has been researched along with Urinary Tract Infections in 6 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Urinary Tract Infections: Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the use and problems of alpha-receptor blockade with prazosin among patients in Nigeria with benign prostatic hyperplasia (BPH) who face a prolonged wait for a prostatectomy." | 3.69 | alpha-receptor blockade for benign prostatic hyperplasia: uses and problems in a developing country. ( Ogbonna, BC; Okeahialam, BN; Ramyil, VM, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, DN | 1 |
| Felder, SI | 1 |
| Luu, M | 1 |
| Daskivich, TJ | 1 |
| N Zaghiyan, K | 1 |
| Fleshner, P | 1 |
| Pérez-Martínez, FC | 1 |
| Vela-Navarrete, R | 1 |
| Virseda, J | 1 |
| Ocaña, AV | 1 |
| Lluel, P | 1 |
| Rekik, M | 1 |
| Bienaymé, H | 1 |
| Ferté, J | 1 |
| Attali, P | 1 |
| Palea, S | 1 |
| Skehan, AM | 1 |
| Downie, JW | 1 |
| Awad, SA | 1 |
| Ogbonna, BC | 1 |
| Okeahialam, BN | 1 |
| Ramyil, VM | 1 |
| Drabick, JJ | 1 |
| Gambel, JM | 1 |
| Mackey, JF | 1 |
| Petersen, MS | 1 |
| Collins, DN | 1 |
| Selakovich, WG | 1 |
| Finkbeiner, AE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optimal Duration of Urinary Catheterization After Total Mesorectal Excision[NCT04359069] | 176 participants (Anticipated) | Interventional | 2020-10-01 | Recruiting | |||
| Acute Urinary Retention After Early, Medium or Late Removal of the Urinary Catheter in Rectal Cancer Surgery. RAOREC Study[NCT04751149] | 143 participants (Anticipated) | Interventional | 2019-05-01 | Recruiting | |||
| Prospective Study Investigating Optimal Duration of Indwelling Urinary Catheter Following Infraperitoneal Colorectal Surgery and Role of Postoperative Alpha Blockade[NCT01923129] | 142 participants (Actual) | Interventional | 2012-11-30 | Completed | |||
| Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial[NCT03314025] | Phase 2 | 158 participants (Anticipated) | Interventional | 2017-10-06 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Urinary tract infection defined as symptomatic urinary complaints such as dysuria, with urinalysis consistent with infection. (NCT01923129)
Timeframe: During 1 week of hospitalization (prior to discharge)
| Intervention | Participants (Count of Participants) |
|---|---|
| 24 Hour Postop Catheter Removal | 0 |
| 72 Hour Postoperative Catheter Removal | 8 |
Acute urinary retention will be defined as catheter discontinuation with inability to void 6 hours post-removal, or void with post-void residual greater than 200 cc of urine. (NCT01923129)
Timeframe: Postoperative day 1 or postpoperative 3 depending on group randomization
| Intervention | Participants (Count of Participants) |
|---|---|
| 24 Hour Postop Catheter Removal | 6 |
| 72 Hour Postoperative Catheter Removal | 7 |
1 trial available for prazosin and Urinary Tract Infections
| Article | Year |
|---|---|
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Colorectal Surgery; Device Removal; F | 2018 |
5 other studies available for prazosin and Urinary Tract Infections
| Article | Year |
|---|---|
Halothane-anesthetized rabbit: a new experimental model to test the effects of besipirdine and duloxetine on lower urinary tract function.
Topics: Anesthesia; Anesthetics; Animals; Atomoxetine Hydrochloride; Disease Models, Animal; Dose-Response R | 2011 |
The pathophysiology of contractile activity in the chronic decentralized feline bladder.
Topics: Adrenergic Fibers; Animals; Atropine; Cats; Denervation; Male; Muscle Contraction; Oxidopamine; Praz | 1993 |
alpha-receptor blockade for benign prostatic hyperplasia: uses and problems in a developing country.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Heart Diseases; Humans; Hypertension; Male; M | 1997 |
Prostatodynia in United Nations peacekeeping forces in Haiti.
Topics: Abscess; Adrenergic alpha-Antagonists; Adult; Age Factors; Anti-Bacterial Agents; Chronic Disease; C | 1997 |
Postoperative urinary retention associated with total hip and total knee arthroplasties.
Topics: Aged; Anesthesia; Hip Prosthesis; Humans; Incidence; Knee Prosthesis; Male; Middle Aged; Postoperati | 1991 |